• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

痘苗病毒在去核BSC-1细胞中的复制:病毒粒子产生以及病毒DNA和蛋白质的合成

Vaccinia virus replication in enucleate BSC-1 cells: particle production and synthesis of viral DNA and proteins.

作者信息

Pennington T H, Follett E A

出版信息

J Virol. 1974 Feb;13(2):488-93. doi: 10.1128/JVI.13.2.488-493.1974.

DOI:10.1128/JVI.13.2.488-493.1974
PMID:4204192
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC355320/
Abstract

The growth of vaccinia virus in monolayers of BSC-1 cells enucleated by centrifugation in the presence of cytochalasin B has been studied. No evidence for the production of infectious virus in these cells was obtained, and the production of virus particles was reduced to 8.3% compared with the yield from cytochalasin-treated, uncentrifuged cells. Virus DNA and early and late polypeptides were synthesized with normal timing in enucleate cells, but in reduced amounts; cleavage of structural polypeptide precursors P4a and Px also occurred in enucleate cells. Factories containing immature virus particles were demonstrated in enucleate cells by electron microscopy; these factories were reduced in number and size compared with those found in cytochalasin-treated, uncentrifuged cells.

摘要

研究了在细胞松弛素B存在下通过离心去核的BSC - 1细胞单层中痘苗病毒的生长情况。未获得这些细胞产生传染性病毒的证据,与经细胞松弛素处理但未离心的细胞相比,病毒颗粒的产量降至8.3%。在去核细胞中,病毒DNA以及早期和晚期多肽按正常时间合成,但量减少;结构多肽前体P4a和Px的切割也发生在去核细胞中。通过电子显微镜在去核细胞中证实了含有未成熟病毒颗粒的工厂;与在经细胞松弛素处理但未离心的细胞中发现的工厂相比,这些工厂的数量和大小减少。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b516/355320/27ce35014161/jvirol00242-0251-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b516/355320/0b2beb6ce666/jvirol00242-0249-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b516/355320/620f42f13bbb/jvirol00242-0250-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b516/355320/27ce35014161/jvirol00242-0251-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b516/355320/0b2beb6ce666/jvirol00242-0249-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b516/355320/620f42f13bbb/jvirol00242-0250-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b516/355320/27ce35014161/jvirol00242-0251-a.jpg

相似文献

1
Vaccinia virus replication in enucleate BSC-1 cells: particle production and synthesis of viral DNA and proteins.痘苗病毒在去核BSC-1细胞中的复制:病毒粒子产生以及病毒DNA和蛋白质的合成
J Virol. 1974 Feb;13(2):488-93. doi: 10.1128/JVI.13.2.488-493.1974.
2
Virus replication in enucleate cells: vesicular stomatitis virus and influenza virus.无细胞核细胞中的病毒复制:水疱性口炎病毒和流感病毒。
J Virol. 1974 Feb;13(2):394-9. doi: 10.1128/JVI.13.2.394-399.1974.
3
Vaccinia virus polypeptide synthesis: sequential appearance and stability of pre- and post-replicative polypeptides.牛痘病毒多肽合成:复制前和复制后多肽的顺序出现及稳定性
J Gen Virol. 1974 Dec;25(3):433-44. doi: 10.1099/0022-1317-25-3-433.
4
Replication of simian virus 40 in permissive cells: assembly of virus components.猴病毒40在允许性细胞中的复制:病毒成分的组装。
J Gen Virol. 1974 Oct;25(1):37-51. doi: 10.1099/0022-1317-25-1-37.
5
Vaccinia virus replication. I. Requirement for the host-cell nucleus.牛痘病毒复制。I. 对宿主细胞核的需求。
J Virol. 1979 Feb;29(2):705-15. doi: 10.1128/JVI.29.2.705-715.1979.
6
An isatin beta-thiosemicarbazone (IBT)-dependent mutant of vaccinia virus: the nature of the IBT-dependent step.一种依赖异吲哚酮β-硫代半卡巴腙(IBT)的痘苗病毒突变体:依赖IBT步骤的性质。
J Gen Virol. 1973 Dec;21(3):477-84. doi: 10.1099/0022-1317-21-3-477.
7
Virus development in enucleate cells: echovirus, poliovirus, pseudorabies virus, reovirus, respiratory syncytial virus and Semliki Forest virus.无核细胞中的病毒发育:艾柯病毒、脊髓灰质炎病毒、伪狂犬病病毒、呼肠孤病毒、呼吸道合胞病毒和Semliki森林病毒。
J Gen Virol. 1975 Feb;26(2):183-96. doi: 10.1099/0022-1317-26-2-183.
8
Vaccinia virus structural polypeptide derived from a high-molecular-weight precursor: formation and integration into virus particles.源自高分子量前体的痘苗病毒结构多肽:形成及整合入病毒颗粒
J Virol. 1970 Dec;6(6):717-26. doi: 10.1128/JVI.6.6.717-726.1970.
9
Establishment and maintenance of the interferon-induced antiviral state: studies in enucleated cells.干扰素诱导的抗病毒状态的建立与维持:去核细胞研究
J Virol. 1974 Mar;13(3):623-30. doi: 10.1128/JVI.13.3.623-630.1974.
10
Biochemical and electron microscopic observations of vaccinia virus morphogenesis in HeLa cells after hydroxyurea reversal.羟基脲逆转后HeLa细胞中牛痘病毒形态发生的生化与电子显微镜观察
Virology. 1974 Oct;61(2):376-96. doi: 10.1016/0042-6822(74)90275-x.

引用本文的文献

1
Structural insight into the assembly and working mechanism of helicase-primase D5 from Mpox virus.结构洞察痘苗病毒解旋酶-引发酶 D5 的组装和工作机制。
Nat Struct Mol Biol. 2024 Jan;31(1):68-81. doi: 10.1038/s41594-023-01142-0. Epub 2024 Jan 4.
2
Modulation of Early Host Innate Immune Response by an Avipox Vaccine Virus' Lateral Body Protein.禽痘疫苗病毒侧体蛋白对宿主早期固有免疫反应的调节
Biomedicines. 2020 Dec 19;8(12):634. doi: 10.3390/biomedicines8120634.
3
Rapid poxvirus engineering using CRISPR/Cas9 as a selection tool.

本文引用的文献

1
THE REPLICATION AND COATING OF VACCINIA DNA.痘苗病毒DNA的复制与包膜化
J Mol Biol. 1964 Dec;10:452-74. doi: 10.1016/s0022-2836(64)80066-8.
2
The purification fo four strains of poxvirus.四种痘病毒株的纯化
Virology. 1962 Sep;18:9-18. doi: 10.1016/0042-6822(62)90172-1.
3
Effects of cytochalasins on mammalian cells.细胞松弛素对哺乳动物细胞的影响。
使用CRISPR/Cas9作为筛选工具进行快速痘病毒工程改造。
Commun Biol. 2020 Nov 3;3(1):643. doi: 10.1038/s42003-020-01374-6.
4
Mutagenic repair of double-stranded DNA breaks in vaccinia virus genomes requires cellular DNA ligase IV activity in the cytosol.双链 DNA 断裂的诱变修复在痘病毒基因组中需要细胞 DNA 连接酶 IV 在细胞质中的活性。
J Gen Virol. 2018 Jun;99(6):790-804. doi: 10.1099/jgv.0.001034. Epub 2018 Apr 20.
5
Low-resolution structure of vaccinia virus DNA replication machinery.痘苗病毒 DNA 复制机器的低分辨率结构。
J Virol. 2013 Feb;87(3):1679-89. doi: 10.1128/JVI.01533-12. Epub 2012 Nov 21.
6
Frog virus 3 replication: induction and intracellular distribution of polypeptides in infected cells.蛙病毒3的复制:感染细胞中多肽的诱导及细胞内分布
J Virol. 1980 Jan;33(1):28-51. doi: 10.1128/JVI.33.1.28-51.1980.
7
A cellular factor is required for transcription of vaccinia viral intermediate-stage genes.痘苗病毒中期基因转录需要一种细胞因子。
Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):3794-8. doi: 10.1073/pnas.91.9.3794.
8
An etoposide-induced block in vaccinia virus telomere resolution is dependent on the virus-encoded DNA ligase.依托泊苷诱导的痘苗病毒端粒分辨率阻滞依赖于病毒编码的DNA连接酶。
J Virol. 1995 Apr;69(4):2082-91. doi: 10.1128/JVI.69.4.2082-2091.1995.
9
Isolation of vaccinia virus mutants capable of replicating independently of the host cell nucleus.能够独立于宿主细胞核进行复制的痘苗病毒突变体的分离。
J Virol. 1984 Aug;51(2):359-66. doi: 10.1128/JVI.51.2.359-366.1984.
10
Biochemical and genetic characterization of vaccinia virus temperature-sensitive mutants with DNA- and DNAf-phenotypes.具有DNA和DNAf表型的痘苗病毒温度敏感突变体的生化与遗传学特征分析
Arch Virol. 1983;77(2-4):209-21. doi: 10.1007/BF01309268.
Nature. 1967 Jan 21;213(5073):261-4. doi: 10.1038/213261a0.
4
Initiation of vaccinia virus infection in actinomycin D-pretreated cells.在经放线菌素D预处理的细胞中启动痘苗病毒感染。
J Virol. 1968 Jul;2(7):678-85. doi: 10.1128/JVI.2.7.678-685.1968.
5
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.在噬菌体T4头部组装过程中结构蛋白的切割
Nature. 1970 Aug 15;227(5259):680-5. doi: 10.1038/227680a0.
6
Analysis of C14-labeled proteins by disc electrophoresis.通过圆盘电泳分析C14标记的蛋白质。
Biochem Biophys Res Commun. 1965 Aug 16;20(4):393-9. doi: 10.1016/0006-291x(65)90589-9.
7
Formation of a vaccinia virus structural polypeptide from a higher molecular weight precursor: inhibition by rifampicin.由高分子量前体形成痘苗病毒结构多肽:利福平的抑制作用。
Proc Natl Acad Sci U S A. 1970 Jul;66(3):677-84. doi: 10.1073/pnas.66.3.677.
8
Replication of vaccinia virus DNA in enucleated L-cells.痘苗病毒DNA在去核L细胞中的复制
J Mol Biol. 1971 Aug 14;59(3):505-8. doi: 10.1016/0022-2836(71)90313-5.
9
Enucleation of mammalian cells with cytochalasin B.用细胞松弛素B去除哺乳动物细胞的细胞核
Exp Cell Res. 1972;71(2):480-5. doi: 10.1016/0014-4827(72)90322-9.
10
Virus replication in enucleate cells: vesicular stomatitis virus and influenza virus.无细胞核细胞中的病毒复制:水疱性口炎病毒和流感病毒。
J Virol. 1974 Feb;13(2):394-9. doi: 10.1128/JVI.13.2.394-399.1974.